- Home
- CEP vs SEPN Comparison
CEP vs SEPN Comparison
Compare CEP & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEP
- SEPN
- Stock Information
- Founded
- CEP 2020
- SEPN 2022
- Country
- CEP United States
- SEPN United States
- Employees
- CEP N/A
- SEPN N/A
- Industry
- CEP
- SEPN
- Sector
- CEP
- SEPN
- Exchange
- CEP NYSE
- SEPN NYSE
- Market Cap
- CEP 516.2M
- SEPN 453.2M
- IPO Year
- CEP 2024
- SEPN 2024
- Fundamental
- Price
- CEP $33.20
- SEPN $10.41
- Analyst Decision
- CEP
- SEPN Buy
- Analyst Count
- CEP 0
- SEPN 4
- Target Price
- CEP N/A
- SEPN $27.00
- AVG Volume (30 Days)
- CEP 1.1M
- SEPN 559.2K
- Earning Date
- CEP 01-01-0001
- SEPN 08-15-2025
- Dividend Yield
- CEP N/A
- SEPN N/A
- EPS Growth
- CEP N/A
- SEPN N/A
- EPS
- CEP 0.25
- SEPN N/A
- Revenue
- CEP N/A
- SEPN $977,000.00
- Revenue This Year
- CEP N/A
- SEPN N/A
- Revenue Next Year
- CEP N/A
- SEPN $526.96
- P/E Ratio
- CEP $131.51
- SEPN N/A
- Revenue Growth
- CEP N/A
- SEPN 108.76
- 52 Week Low
- CEP $9.99
- SEPN $4.17
- 52 Week High
- CEP $59.75
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- CEP N/A
- SEPN N/A
- Support Level
- CEP N/A
- SEPN N/A
- Resistance Level
- CEP N/A
- SEPN N/A
- Average True Range (ATR)
- CEP 0.00
- SEPN 0.00
- MACD
- CEP 0.00
- SEPN 0.00
- Stochastic Oscillator
- CEP 0.00
- SEPN 0.00
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.